Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEE-guided Dobutamine Strategy in Laparoscopic Hepatectomy
NCT06210217Phase 1Not yet recruiting
- Sponsor
- Sichuan University
- Start
- Feb 2024
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dobutamine (2 arms), sponsored by Sichuan University. Primary endpoint: Variation of hepatic venous blood flow spectrum. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
dobutamine
Beyond the preview
Go deeper on NCT06210217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06210217.